# Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea

> **NCT00547898** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 374 (actual)

## Conditions studied

- HIV Associated Diarrhea

## Interventions

- **DRUG:** Crofelemer 125 mg
- **DRUG:** Crofelemer 250 mg
- **DRUG:** Crofelemer 500 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00547898
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-01-27
- **Final completion:** 2011-07-11
- **Target enrollment:** 374 (ACTUAL)
- **Last updated:** 2020-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547898, "Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00547898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*